EUVIMEDEUVIMED entdecken
Crossref

A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease

Nitika Sindhu, Smita Jain, Swapnil Sharma, Swati Paliwal

ACS Chemical Neuroscience · 27.10.2026

DOI: 10.1021/acschemneuro.6c00379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 27.10.2026. Verfasst von Nitika Sindhu und 3 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Department of Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is an early pathological aspect of Alzheimer’s disease (AD) that promotes oxidative stress, leading to amyloid β-plaque formation and neurofibrillary tangles. Thus, targeted mitochondrial therapy and mitochondrial transplantation have emerged as promising therapeutic strategies. However, excessive oxidative stress and neuroinflammation in the microenvironments of the AD brain limit the functional and stable integration of transplanted mitochondria. In this study, we have engineered a Mito-CoQ10-TPP hybrid nanocarrier by conjugating triphenylphosphonium (TPP), a lipophilic cation, with Coenzyme Q10 (CoQ10) and localized it to mitochondria isolated from healthy cortical brain cells. This nanocarrier hybrid was administered via a single intravenous (IV) dose to streptozotocin (STZ)-induced AD in mice. A comprehensive evaluation of mitochondrial function, amyloid burden, neuroinflammation, apoptosis, biogenesis, and behavior revealed that CoQ10-TPP conjugation significantly improved the mitochondrial transplantation efficacy in the amelioration of AD. Thus, conjugating the antioxidant CoQ10 with mitochondrial transplantation significantly improved the overall therapeutic efficacy, indicating the use of the Mito-CoQ10-TPP hybrid nanocarrier as a promising therapeutic strategy.

Förderung

  • Department of Science and Technology

Zitieren

APA

Sindhu, N., Jain, S., Sharma, S., & Paliwal, S. (2026). A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00379

Vancouver

Sindhu N, Jain S, Sharma S, Paliwal S. A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease. ACS Chemical Neuroscience. 2026. doi:10.1021/acschemneuro.6c00379

BibTeX
@article{Sindhu2026,
  author = {Sindhu, Nitika and Jain, Smita and Sharma, Swapnil and Paliwal, Swati},
  title = {A Mito-CoQ10-TPP Nanocarrier Hybrid Enhances the Therapeutic Efficacy of Mitochondrial Transplantation in Alzheimer’s Disease},
  journal = {ACS Chemical Neuroscience},
  year = {2026},
  doi = {10.1021/acschemneuro.6c00379}
}
Kostenlos starten →